Biotech M&A Trends With Allan Shaw
Business Of Biotech
00:00
M&A Collaborations Provide the Most Cost-Effective Framework
M&A collaborations will continue to provide the most cost-effective framework, particularly given the business cycle that we're entering. I just think that when the capital spigot was running as much as it was, and the cost of capital was so much lower, people had luxuries that now maybe they should not be pursuing anymore.
Transcript
Play full episode
